What is the Fiscal Year for CytoDyn?
Date: November 13, 2026
CytoDyn's current fiscal year starts on June 1, 2026, and ends on May 31, 2027. Their current quarter is Q2, which ends on November 30, 2026.
Current Fiscal Year Overview
Fiscal Year Start
June 1, 2026
Fiscal Year End
May 31, 2027
Current Quarter
Q2
Current Quarter End
November 30, 2026
Quarterly Breakdown
Q1
Jun 1, 2026 – Aug 31, 2026
Q2
Sep 1, 2026 – Nov 30, 2026
Q3
Dec 1, 2026 – Feb 28, 2027
Q4
Mar 1, 2027 – May 31, 2027
Company Information
Headquarters
VANCOUVER, Washington
Industry
Biotechnology Research
Stock Symbol
CYDY
Website
https://cytodyn.comDescription
CytoDyn Inc. is a clinical-stage oncology company advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor with therapeutic potential across multiple therapeutic indications.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like CytoDyn and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.